Feel Therapeutics
San Francisco, US · Founded 2015 · Delaware corporation · 5 known investors
Feel Therapeutics develops digital biomarkers and digital health solutions for mental health treatment, designed to function as standalone programs or alongside medications. The company operates within the digital precision medicine space and partners with pharmaceutical and biotech firms on clinical development and commercialization.
Founders & leadership
GE
Georgios EleftheriouExecutive Officer, Director, Promoter
CT
Charalampos TsirmpasExecutive Officer, Director, Promoter
IF
Irini FragkiskouExecutive Officer
VM
Vica ManosDirector
MV
Michel VounatsosinChairman of the advisory board, former CEO of Biogen
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$7.9MraisedApr 2025 · 34 investors · Other TechnologyRule 506(b)
▶$7.9MraisedApr 2025 · 34 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Vica ManosDirector
- Georgios EleftheriouExecutive Officer, Director, Promoter
- Charalampos TsirmpasExecutive Officer, Director, Promoter
- Offering amount
- $9M
- Amount sold
- $7.9M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedNov 2019 · 13 investors · Other TechnologyRule 506(b)
▶$6.2MraisedNov 2019 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Georgios EleftheriouExecutive Officer, Director, Promoter
- Charalampos TsirmpasExecutive Officer, Director, Promoter
- Vica ManosDirector
- Irini FragkiskouExecutive Officer
- Offering amount
- $6.2M
- Amount sold
- $6.2M
- Proceeds to insiders
- $600K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.